author_facet Berndt, Sonja I.
Chatterjee, Nilanjan
Huang, Wen-Yi
Chanock, Stephen J.
Welch, Robert
Crawford, E. David
Hayes, Richard B.
Berndt, Sonja I.
Chatterjee, Nilanjan
Huang, Wen-Yi
Chanock, Stephen J.
Welch, Robert
Crawford, E. David
Hayes, Richard B.
author Berndt, Sonja I.
Chatterjee, Nilanjan
Huang, Wen-Yi
Chanock, Stephen J.
Welch, Robert
Crawford, E. David
Hayes, Richard B.
spellingShingle Berndt, Sonja I.
Chatterjee, Nilanjan
Huang, Wen-Yi
Chanock, Stephen J.
Welch, Robert
Crawford, E. David
Hayes, Richard B.
Cancer Epidemiology, Biomarkers & Prevention
Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer
Oncology
Epidemiology
author_sort berndt, sonja i.
spelling Berndt, Sonja I. Chatterjee, Nilanjan Huang, Wen-Yi Chanock, Stephen J. Welch, Robert Crawford, E. David Hayes, Richard B. 1055-9965 1538-7755 American Association for Cancer Research (AACR) Oncology Epidemiology http://dx.doi.org/10.1158/1055-9965.epi-06-0689 <jats:title>Abstract</jats:title> <jats:p>Sex hormones have been implicated in prostate carcinogenesis and are thought to modulate cell proliferation and growth. To investigate the association between polymorphisms in hormone-related genes and prostate cancer risk, we conducted a two-stage, case-control study within the screening arm of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Using DNA extracted from blood specimens, we initially genotyped 14 single nucleotide polymorphisms in genes involved in hormone regulation or metabolism (AKR1C3, CYP1A1, CYP1B1, CYP3A4, ESR1, GNRH1, HSD173B, HSD3B2, SHBG, and SRD5A2) in 488 prostate cancer cases and 617 matched controls. Heterozygotes at SHBG D356N were found to be associated with an increased risk of prostate cancer compared with the homozygous wild type, particularly among non-Hispanic whites (odds ratio, 1.54; 95% confidence interval, 1.13-2.09; P = 0.006). No significant associations were observed with the other polymorphisms. The SHBG D356N polymorphism, which has potential functional significance, was subsequently genotyped in additional 769 cases and 1,168 controls. Overall, SHBG D356N heterozygotes were found to have an increased risk of prostate cancer among whites (odds ratio, 1.34; 95% confidence interval, 1.10-1.63; P = 0.0007). This study suggests that genetic variation in SHBG may influence prostate cancer susceptibility. (Cancer Epidemiol Biomarkers Prev 2007;16(1):165–8)</jats:p> Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer Cancer Epidemiology, Biomarkers & Prevention
doi_str_mv 10.1158/1055-9965.epi-06-0689
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTA2LTA2ODk
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTA2LTA2ODk
institution DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
imprint American Association for Cancer Research (AACR), 2007
imprint_str_mv American Association for Cancer Research (AACR), 2007
issn 1055-9965
1538-7755
issn_str_mv 1055-9965
1538-7755
language English
mega_collection American Association for Cancer Research (AACR) (CrossRef)
match_str berndt2007variantinsexhormonebindingglobulingeneandtheriskofprostatecancer
publishDateSort 2007
publisher American Association for Cancer Research (AACR)
recordtype ai
record_format ai
series Cancer Epidemiology, Biomarkers & Prevention
source_id 49
title Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer
title_unstemmed Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer
title_full Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer
title_fullStr Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer
title_full_unstemmed Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer
title_short Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer
title_sort variant in sex hormone-binding globulin gene and the risk of prostate cancer
topic Oncology
Epidemiology
url http://dx.doi.org/10.1158/1055-9965.epi-06-0689
publishDate 2007
physical 165-168
description <jats:title>Abstract</jats:title> <jats:p>Sex hormones have been implicated in prostate carcinogenesis and are thought to modulate cell proliferation and growth. To investigate the association between polymorphisms in hormone-related genes and prostate cancer risk, we conducted a two-stage, case-control study within the screening arm of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Using DNA extracted from blood specimens, we initially genotyped 14 single nucleotide polymorphisms in genes involved in hormone regulation or metabolism (AKR1C3, CYP1A1, CYP1B1, CYP3A4, ESR1, GNRH1, HSD173B, HSD3B2, SHBG, and SRD5A2) in 488 prostate cancer cases and 617 matched controls. Heterozygotes at SHBG D356N were found to be associated with an increased risk of prostate cancer compared with the homozygous wild type, particularly among non-Hispanic whites (odds ratio, 1.54; 95% confidence interval, 1.13-2.09; P = 0.006). No significant associations were observed with the other polymorphisms. The SHBG D356N polymorphism, which has potential functional significance, was subsequently genotyped in additional 769 cases and 1,168 controls. Overall, SHBG D356N heterozygotes were found to have an increased risk of prostate cancer among whites (odds ratio, 1.34; 95% confidence interval, 1.10-1.63; P = 0.0007). This study suggests that genetic variation in SHBG may influence prostate cancer susceptibility. (Cancer Epidemiol Biomarkers Prev 2007;16(1):165–8)</jats:p>
container_issue 1
container_start_page 165
container_title Cancer Epidemiology, Biomarkers & Prevention
container_volume 16
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792339325526999055
geogr_code not assigned
last_indexed 2024-03-01T15:45:53.268Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Variant+in+Sex+Hormone-Binding+Globulin+Gene+and+the+Risk+of+Prostate+Cancer&rft.date=2007-01-01&genre=article&issn=1538-7755&volume=16&issue=1&spage=165&epage=168&pages=165-168&jtitle=Cancer+Epidemiology%2C+Biomarkers+%26+Prevention&atitle=Variant+in+Sex+Hormone-Binding+Globulin+Gene+and+the+Risk+of+Prostate+Cancer&aulast=Hayes&aufirst=Richard+B.&rft_id=info%3Adoi%2F10.1158%2F1055-9965.epi-06-0689&rft.language%5B0%5D=eng
SOLR
_version_ 1792339325526999055
author Berndt, Sonja I., Chatterjee, Nilanjan, Huang, Wen-Yi, Chanock, Stephen J., Welch, Robert, Crawford, E. David, Hayes, Richard B.
author_facet Berndt, Sonja I., Chatterjee, Nilanjan, Huang, Wen-Yi, Chanock, Stephen J., Welch, Robert, Crawford, E. David, Hayes, Richard B., Berndt, Sonja I., Chatterjee, Nilanjan, Huang, Wen-Yi, Chanock, Stephen J., Welch, Robert, Crawford, E. David, Hayes, Richard B.
author_sort berndt, sonja i.
container_issue 1
container_start_page 165
container_title Cancer Epidemiology, Biomarkers & Prevention
container_volume 16
description <jats:title>Abstract</jats:title> <jats:p>Sex hormones have been implicated in prostate carcinogenesis and are thought to modulate cell proliferation and growth. To investigate the association between polymorphisms in hormone-related genes and prostate cancer risk, we conducted a two-stage, case-control study within the screening arm of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Using DNA extracted from blood specimens, we initially genotyped 14 single nucleotide polymorphisms in genes involved in hormone regulation or metabolism (AKR1C3, CYP1A1, CYP1B1, CYP3A4, ESR1, GNRH1, HSD173B, HSD3B2, SHBG, and SRD5A2) in 488 prostate cancer cases and 617 matched controls. Heterozygotes at SHBG D356N were found to be associated with an increased risk of prostate cancer compared with the homozygous wild type, particularly among non-Hispanic whites (odds ratio, 1.54; 95% confidence interval, 1.13-2.09; P = 0.006). No significant associations were observed with the other polymorphisms. The SHBG D356N polymorphism, which has potential functional significance, was subsequently genotyped in additional 769 cases and 1,168 controls. Overall, SHBG D356N heterozygotes were found to have an increased risk of prostate cancer among whites (odds ratio, 1.34; 95% confidence interval, 1.10-1.63; P = 0.0007). This study suggests that genetic variation in SHBG may influence prostate cancer susceptibility. (Cancer Epidemiol Biomarkers Prev 2007;16(1):165–8)</jats:p>
doi_str_mv 10.1158/1055-9965.epi-06-0689
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTA2LTA2ODk
imprint American Association for Cancer Research (AACR), 2007
imprint_str_mv American Association for Cancer Research (AACR), 2007
institution DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1
issn 1055-9965, 1538-7755
issn_str_mv 1055-9965, 1538-7755
language English
last_indexed 2024-03-01T15:45:53.268Z
match_str berndt2007variantinsexhormonebindingglobulingeneandtheriskofprostatecancer
mega_collection American Association for Cancer Research (AACR) (CrossRef)
physical 165-168
publishDate 2007
publishDateSort 2007
publisher American Association for Cancer Research (AACR)
record_format ai
recordtype ai
series Cancer Epidemiology, Biomarkers & Prevention
source_id 49
spelling Berndt, Sonja I. Chatterjee, Nilanjan Huang, Wen-Yi Chanock, Stephen J. Welch, Robert Crawford, E. David Hayes, Richard B. 1055-9965 1538-7755 American Association for Cancer Research (AACR) Oncology Epidemiology http://dx.doi.org/10.1158/1055-9965.epi-06-0689 <jats:title>Abstract</jats:title> <jats:p>Sex hormones have been implicated in prostate carcinogenesis and are thought to modulate cell proliferation and growth. To investigate the association between polymorphisms in hormone-related genes and prostate cancer risk, we conducted a two-stage, case-control study within the screening arm of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Using DNA extracted from blood specimens, we initially genotyped 14 single nucleotide polymorphisms in genes involved in hormone regulation or metabolism (AKR1C3, CYP1A1, CYP1B1, CYP3A4, ESR1, GNRH1, HSD173B, HSD3B2, SHBG, and SRD5A2) in 488 prostate cancer cases and 617 matched controls. Heterozygotes at SHBG D356N were found to be associated with an increased risk of prostate cancer compared with the homozygous wild type, particularly among non-Hispanic whites (odds ratio, 1.54; 95% confidence interval, 1.13-2.09; P = 0.006). No significant associations were observed with the other polymorphisms. The SHBG D356N polymorphism, which has potential functional significance, was subsequently genotyped in additional 769 cases and 1,168 controls. Overall, SHBG D356N heterozygotes were found to have an increased risk of prostate cancer among whites (odds ratio, 1.34; 95% confidence interval, 1.10-1.63; P = 0.0007). This study suggests that genetic variation in SHBG may influence prostate cancer susceptibility. (Cancer Epidemiol Biomarkers Prev 2007;16(1):165–8)</jats:p> Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer Cancer Epidemiology, Biomarkers & Prevention
spellingShingle Berndt, Sonja I., Chatterjee, Nilanjan, Huang, Wen-Yi, Chanock, Stephen J., Welch, Robert, Crawford, E. David, Hayes, Richard B., Cancer Epidemiology, Biomarkers & Prevention, Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer, Oncology, Epidemiology
title Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer
title_full Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer
title_fullStr Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer
title_full_unstemmed Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer
title_short Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer
title_sort variant in sex hormone-binding globulin gene and the risk of prostate cancer
title_unstemmed Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer
topic Oncology, Epidemiology
url http://dx.doi.org/10.1158/1055-9965.epi-06-0689